Delix Therapeutics

Clinical-stage biotechnology company developing non-hallucinogenic neuroplasticity-promoting therapeutics for psychiatric and neurological disorders based on psychedelic compound research.

Location
Boston, Massachusetts, USA
Founded
2019
Investors
1
Categories
therapeutics, psychiatry, neurology, neuroplasticity, biotech

Investors

NameLocationTypeStagesPortfolio
OMX VenturesSan Francisco, California, USAbiotech-focused
seedseries-a
23